Enzymco Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.40 Cr
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -8.42%
- Profit Growth 23.07%
- Ebitda -450.76%
- Net Worth 35.71%
- Total Assets 70.84%
About Enzymco
Enzymco Private Limited (EPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 June 2018 (Six years and eight months 15 days old ). Its registered office is in Virudhunagar, Tamil Nadu, India.
The Corporate was formerly known as Phytozymes Enterprises India Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rengaraj Kannan, Rengaraj Vijayalakshmi, Thibaut Hofman, and One other member serve as directors at the Company.
Company Details
- Location
Virudhunagar, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U15140TN2018PTC123207
- Company No.
123207
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Enzymco?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rengaraj Kannan  | Managing Director | 13-Jun-2018 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rengaraj Vijayalakshmi | Director | 13-Jun-2018 | Current |
Thibaut Hofman  | Director | 02-Sep-2019 | Current |
| Stefaan Vandaele | Director | 22-Sep-2021 | Current |
Financial Performance of Enzymco.
Enzymco Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.42% decrease. The company also saw a substantial improvement in profitability, with a 23.07% increase in profit. The company's net worth Soared by an impressive increase of 35.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enzymco?
In 2021, Enzymco had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phytozymes Biotech Private LimitedRengaraj Kannan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Enzymco?
Unlock and access historical data on people associated with Enzymco, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enzymco, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzymco's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
